Literature DB >> 25205809

Toward a unified therapeutics approach targeting putative amyloid-β oligomer receptors.

Cassia R Overk1, Eliezer Masliah2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25205809      PMCID： PMC4183328          DOI： 10.1073/pnas.1414554111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 2.  Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.

Authors:  Aarti N Patel; Jack H Jhamandas
Journal:  Expert Rev Mol Med       Date:  2012-01-20       Impact factor: 5.600

3.  Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes.

Authors:  Tai-Hyun Kang; Yukihisa Murakami; Kinzo Matsumoto; Hiromitsu Takayama; Mariko Kitajima; Norio Aimi; Hiroshi Watanabe
Journal:  Eur J Pharmacol       Date:  2002-11-22       Impact factor: 4.432

4.  Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Authors:  Maria Talantova; Sara Sanz-Blasco; Xiaofei Zhang; Peng Xia; Mohd Waseem Akhtar; Shu-ichi Okamoto; Gustavo Dziewczapolski; Tomohiro Nakamura; Gang Cao; Alexander E Pratt; Yeon-Joo Kang; Shichun Tu; Elena Molokanova; Scott R McKercher; Samuel Andrew Hires; Hagit Sason; David G Stouffer; Matthew W Buczynski; James P Solomon; Sarah Michael; Evan T Powers; Jeffery W Kelly; Amanda Roberts; Gary Tong; Traci Fang-Newmeyer; James Parker; Emily A Holland; Dongxian Zhang; Nobuki Nakanishi; H-S Vincent Chen; Herman Wolosker; Yuqiang Wang; Loren H Parsons; Rajesh Ambasudhan; Eliezer Masliah; Stephen F Heinemann; Juan C Piña-Crespo; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

5.  Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord.

Authors:  Jez Fabes; Patrick Anderson; Caroline Brennan; Stephen Bolsover
Journal:  Eur J Neurosci       Date:  2007-10-26       Impact factor: 3.386

6.  Effects of natural flavones and flavonols on the kinase activity of Cdk5.

Authors:  Gerald Zapata-Torres; Felipe Opazo; Cristián Salgado; Juan Pablo Muñoz; Hans Krautwurst; Carolina Mascayano; Silvia Sepúlveda-Boza; Ricardo B Maccioni; Bruce K Cassels
Journal:  J Nat Prod       Date:  2004-03       Impact factor: 4.050

7.  Canonical Wnt signaling protects hippocampal neurons from Aβ oligomers: role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics.

Authors:  Carmen Silva-Alvarez; Macarena S Arrázola; Juan A Godoy; Daniela Ordenes; Nibaldo C Inestrosa
Journal:  Front Cell Neurosci       Date:  2013-06-25       Impact factor: 5.505

8.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

9.  EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice.

Authors:  Yona Goldshmit; Mark D Spanevello; Sophie Tajouri; Li Li; Fiona Rogers; Martin Pearse; Mary Galea; Perry F Bartlett; Andrew W Boyd; Ann M Turnley
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease.

Authors:  Olivia Engmann; Karl Peter Giese
Journal:  Front Mol Neurosci       Date:  2009-05-29       Impact factor: 5.639
View more
  7 in total

1.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

Review 2.  Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease.

Authors:  Tam T Quach; Aubin Moutal; Rajesh Khanna; Nicholas P Deems; Anne-Marie Duchemin; Ruth M Barrientos
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

Authors:  Sergio T Ferreira; Mychael V Lourenco; Mauricio M Oliveira; Fernanda G De Felice
Journal:  Front Cell Neurosci       Date:  2015-05-26       Impact factor: 5.505

Review 4.  Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.

Authors:  Heledd H Jarosz-Griffiths; Elizabeth Noble; Jo V Rushworth; Nigel M Hooper
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

Review 5.  The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.

Authors:  Erika N Cline; Maíra Assunção Bicca; Kirsten L Viola; William L Klein
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting.

Authors:  Marie P Schützmann; Filip Hasecke; Sarah Bachmann; Mara Zielinski; Sebastian Hänsch; Gunnar F Schröder; Hans Zempel; Wolfgang Hoyer
Journal:  Nat Commun       Date:  2021-07-30       Impact factor: 14.919

7.  The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer's Disease.

Authors:  Kirsten L Viola; Maira A Bicca; Adrian M Bebenek; Daniel L Kranz; Vikas Nandwana; Emily A Waters; Chad R Haney; Maxwell Lee; Abhay Gupta; Zachary Brahmbhatt; Weijian Huang; Ting-Tung Chang; Anderson Peck; Clarissa Valdez; Vinayak P Dravid; William L Klein
Journal:  Front Neurosci       Date:  2022-01-03       Impact factor: 5.152
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.